Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOM0226 (tolcapone) TTR stabilization study in familial amyloid polyneuropathy
2014-001586-27Phase 2Terminated
- Sponsor
- SOM Biotech
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tolcapone in familial amyloid polyneuropathy (FAP) (3 arms), sponsored by SOM Biotech. Primary endpoint: TTR stabilization. Started Jun 2014; status: terminated.
02
Drugs
tolcapone
03
Conditions
familial amyloid polyneuropathy (FAP)
Beyond the preview
Go deeper on 2014-001586-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001586-27.